HALZYME

Serial Number 78836493
602

Registration Progress

Application Filed
Mar 14, 2006
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

HALZYME

Basic Information

Serial Number
78836493
Filing Date
March 14, 2006
Abandonment Date
December 29, 2008
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 6, 2009
Classes
001 005

Rights Holder

Halzyme Technologies, Inc.

03
Address
1017 El Camino Real, Suite 303
Redwood City, CA 94063

Ownership History

Halzyme Technologies, Inc.

Original Applicant
03
Redwood City, CA

Legal Representation

Attorney
Albert P. Halluin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description
Feb 6, 2009 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 6, 2009 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 27, 2008 CNRT R NON-FINAL ACTION WRITTEN
Jun 27, 2008 GNRT O NON-FINAL ACTION E-MAILED
Jun 27, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 6, 2008 ALIE A ASSIGNED TO LIE
Jun 6, 2008 RCCK S SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Dec 4, 2007 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 4, 2007 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 4, 2006 ACEC I AMENDMENT FROM APPLICANT ENTERED
Dec 4, 2006 CNSL R SUSPENSION LETTER WRITTEN
Dec 4, 2006 GNSL S LETTER OF SUSPENSION E-MAILED
Dec 1, 2006 ALIE A ASSIGNED TO LIE
Nov 9, 2006 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2006 DOCK D ASSIGNED TO EXAMINER
May 11, 2006 CNRT R NON-FINAL ACTION WRITTEN
May 11, 2006 GNRT F NON-FINAL ACTION E-MAILED
Mar 17, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM

Detailed Classifications

Class 001
enzymes for use in the biotechnology, agricultural and chemical industries
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
pharmaceuticals for the treatment of thrombolytic diseases, heart diseases and vascular disorders
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
HAL ENZYME

Classification

International Classes
001 005

USPTO Documents

Loading USPTO documents...